U.S. Introduces “Fair and Reciprocal Plan,” Marking Significant and Impactful Shift in Trade Policy
2025 Outlook: The Department of Health and Human Services Under the Second Trump Administration – Diagnosing Health Care
The Implications of President Trump's EO on Gender Ideology: What's the Tea in L&E?
Employment Law Now - IX-160 – Trump 2.0 Immigration Policy and Employer Best Practices
Changes at the CFPB Under the Trump Administration
Government Contracts and New Mandates Executive Orders and Cost Recovery Strategies Explained
Consumer Finance Monitor Podcast Episode: Will the State Attorneys General and Other State Agencies Fill the Void Left by the CFPB?
#WorkforceWednesday®: Federal Agencies Begin Compliance Efforts Under Trump Administration - Employment Law This Week®
Preparing Employers for ICE Enforcement
Adapting to Tariffs and Other Trade Policy Shifts Under the Trump Administration
UDAAP and Fair Lending Developments: 2024 Year-in-Review and 2025 Predictions — The Consumer Finance Podcast
The Labor Law Insider: Student Athletes as Employees – Changes and Updates on the Dartmouth Case, NIL Litigation
False Claims Act Insights - How Tariffs Can Increase Whistleblower Activity and Associated FCA Liability
A Brief Primer on Tariffs Under the Trump Administration
Employment Law Now IX-159 - 8th Anniversary Special: The Current State of Politics for Employers
Consumer Finance Monitor Podcast Episode: The Impact of the Election on the CFPB: What to Expect with Supervision and Enforcement During Trump 2.0
Adapting to Changes in a New Presidential Era
#WorkforceWednesday®: Employment Law Changes Under President Trump - Employment Law This Week®
What to Expect from the New FTC Leadership
AGG Talks: Women in Tech Law Podcast - Episode 5: How the Tech Industry Can Monitor Regulatory Changes Under the Trump Administration
The Trump Administration and 119th Congress will likely be targeting trillions of dollars in savings in the year ahead. Healthcare makes up a significant portion of mandatory spending and therefore likely will be a large part...more
Holland & Knight Health Dose Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more
This week in Washington: Both the House and Senate return to session, discussions on the next COVID-19 package begin....more
As the Trump Administration moves forward with proposed policy changes to address high drug prices, a common theme is emerging: a number of the proposals have the potential to reduce Medicare reimbursement to hospitals and...more
On Feb. 9, 2018, the Trump Administration released a 30-page report analyzing domestic and global factors influencing drug pricing. The report by the Council of Economic Advisers (CEA) is expected to inform the HHS' Fiscal...more